SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-007128
Filing Date
2019-02-13
Accepted
2019-02-13 16:02:39
Documents
70
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv512730_10q.htm 10-Q 555380
2 EXHIBIT 31.1 tv512730_ex31-1.htm EX-31.1 10287
3 EXHIBIT 31.2 tv512730_ex31-2.htm EX-31.2 10445
4 EXHIBIT 32.1 tv512730_ex32-1.htm EX-32.1 5452
5 EXHIBIT 32.2 tv512730_ex32-2.htm EX-32.2 5423
  Complete submission text file 0001144204-19-007128.txt   8361678

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ibio-20181231.xml EX-101.INS 2779415
7 XBRL TAXONOMY EXTENSION SCHEMA ibio-20181231.xsd EX-101.SCH 44753
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20181231_cal.xml EX-101.CAL 38096
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20181231_def.xml EX-101.DEF 339816
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20181231_lab.xml EX-101.LAB 346634
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20181231_pre.xml EX-101.PRE 378706
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 19597012
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1